Sebia (Group)

https://www.sebia.com

Sebia develops, manufactures and commercializes protein electrophoresis tests and analyzers dedicated to the in vitro diagnosis of cancer, inflammatory diseases, diabetes and hemoglobin disorders. Sebia’s focus on electrophoresis techniques allows a sustained R&D program, providing access to genuine innovations to any lab. Both agarose gel and capillary assays and their dedicated automation are designed to be integrated into the same routine workflow; for gel (Assist, Hydrasys 2 Scan) and for capillary electrophoresis (Capillays 2, Minicap). In 2011 Sebia introduced Capillarys 2 Flex Piercing, the most advanced capillary technology, providing a high level of performance and walk-away automation. Tests include serum proteins, urine proteins, immunotyping, CDT measurement and hemoglobinopathy screening for whole blood in primary capped tubes. Recently Sebia has diversified its activity in the field of diabetes to fulfill the growing worldwide demand for more accurate and reproducible methods of HbA1c measurement. Sebia now offers a clear-cut and precise HbA1c test on Capillarys 2 Flex Piercing and Minicap Flex Piercing. In 2015, the company launched the high-speed automation electrophoresis program, Capillarys 3. *

	Start	2009-05-19 existent
	Industry	diagnostics (medical/biological)
	Industry 2	capillary electrophoresis (CE)
	Person	Adelus, Benoît (Sebia 200802– before Eurofins EVP + bioMérieux CEO + Merial)

	Region	Évry, Essonne
	Country	France
	Street	CP 8010 Lisses Parc Technologique Leonard de Vinci
	City	91008 Évry
	Tel	+33-1-69898080
		Address record changed: 2020-12-02

Basic data	Employees	n. a.
	Currency	EUR
	Annual sales	153,000,000 (sales turnover (2013) 2013-12-31)

		* Document for »About Section«:

		Record changed: 2024-02-12

Picture [iito] [LSE] Life-Sciences-Europe.com Business Portal 650x200px

More documents for Sebia (Group)

[1] Caisse de Dépot et Placement du Québec (CDPQ). (8/10/17). "Press Release: CDPQ to Acquire Significant Minority Stake in Sebia, a Global Leader in the Medical Diagnostics Sector, from Astorg and Montagu". Paris & Montréal....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]